SCID has the poorest prognosis among combined immunodeficiencies unless bone marrow transplantation or gene therapy (experimental) is successfully performed. In general, for improving the quality of life of patients with primary immunodeficiencies, long-term management with antimicrobials is needed. Most primary immunodeficiencies require personalized management, e.g., genetic testing for various enzyme impairments.